Laerdal Million Lives Fund is a venture capital firm that focuses on investments in life-saving technologies. Its investment thesis aims to contribute to Laerdal’s impact goal of helping save 1 million lives annually by 2030. The firm targets investments in commercial-stage technologies that address mortality rates across clinical areas, such as
maternal, neonatal, emergency medicine, critical care, surgery, and others and provide better medical education and training to providers and patients.